What Allergoval Treats: Main Uses and Benefits

Allergoval is primarily relevant for easing symptoms related to food hypersensitivity, a condition where additional symptomatic support is needed. It is commonly used to help with symptom clusters that may become intense or disruptive in patients with food allergy. This support is used for managing symptoms related to physical discomfort, such as hives, itching, abdominal pain, and diarrhea.

The medication is relevant in conditions characterized by periods of heightened symptoms and is often used when symptoms intensify and supportive relief is needed. This approach is applied in addressing manifestations that affect different parts of the body. The treatment provides support that helps ease the overall symptom burden, and may help patients cope more steadily with symptom fluctuations. As part of symptomatic management, it contributes to easing the overall symptom load and supports general well-being during symptomatic phases.

---

Quick Fact: Relevant for Easing Symptoms in Gastrointestinal and Skin Domains

Regulatory References

1. Health Canada Product Monograph on Sodium Cromoglycate

Who Can and Cannot Use Allergoval? (Official Regulatory Information)

Eligibility to use Allergoval (oral Sodium Cromoglycate capsules) is defined by official government regulatory standards, focusing strictly on population suitability and contraindications.

---

Eligibility and Non-Eligibility Status

Classification	Population Group	Regulatory Status
Absolute Contraindication	Individuals with known hypersensitivity to Sodium Cromoglycate or any excipient	Must not use (Prohibited)
Age Restriction	Infants and children under 2 years of age	Not Recommended (Safety and efficacy not established)
Conditional Use	Pregnant individuals (First Trimester)	Not Recommended (Use must be considered essential)
Conditional Use	Patients with impaired renal function	Caution Advised (Drug is primarily excreted by the kidneys)
Established Use	Adults and adolescents (typically ge 14 years of age)	Generally Allowed
Established Use	Breastfeeding individuals	Generally Allowed (Low systemic absorption)

Official documents affirm the use of this medicine in eligible adult and adolescent populations for its stated prophylactic purpose. However, use is formally contraindicated in any patient with a known allergy to the active ingredient. Conditional use applies to specific groups, emphasizing caution in those with kidney impairment and recommending avoidance in the first trimester of pregnancy.

Interactions with other medicines and products

The official regulatory profile for Allergoval (Sodium Cromoglycate oral capsules) is characterized by a minimal risk of drug–drug interaction, primarily due to the active substance's negligible systemic absorption and non-metabolized clearance pathway.

Drug–Drug Interaction Profile

No formal contraindications or clinically significant drug–drug interactions are documented in official regulatory prescribing information. The negligible systemic concentration and excretion of the unchanged substance via the biliary and renal routes mean the product is not associated with common metabolic interactions, such as those involving cytochrome P450 enzymes or major transport proteins.

Food, Liquids, and Exposure Constraints

A pharmacokinetic interaction is officially documented with certain substances consumed at the time of administration:

• Interacting Substances: Food, including milk and fruit juices, is documented to interfere with the absorption of the active ingredient.
• Interaction Outcome: This interference results in a reduction of the drug's systemic exposure.
• Restriction: To counteract this effect, regulatory documentation states a mandatory administration constraint requiring the separation of the product from meals and these specific liquids.

Population-Specific Considerations

Official labeling includes a caution regarding patients with compromised organ function:

• Altered Clearance: Since the drug is excreted as the unchanged substance via both renal and biliary pathways, there is a documented risk of accumulation in patients with significantly reduced hepatic or renal function.
• Regulatory Note: This finding establishes a population-specific constraint related to the risk of increased exposure (accumulation).

Stabilizing the Mast Cell Membrane

Allergoval (cromoglicic acid) is classified as a mast cell stabilizer that exerts its action primarily at peripheral mucosal sites, such as the gastrointestinal tract and airways. The molecule interacts with and stabilizes the membrane of the mast cell . This interaction mechanically inhibits the critical cellular process of degranulation by preventing the necessary influx of calcium ions ( Ca^2+) required to trigger granule exocytosis.

Blocking the Inflammatory Mediator Cascade

By stabilizing the mast cell, the drug suppresses activity within the Immediate Hypersensitivity Pathway. This directly blocks the rapid release of pre-formed inflammatory mediators, including histamine and leukotrienes, into the local tissue environment.

Limiting Peripheral Physiological Effects

This mechanistic cascade results in lowered concentrations of released mediators, which in turn modulates the activity of peripheral tissue responses. The consequence is a reduction in mediator-driven increases in vascular permeability and a decrease in smooth muscle contractility within the affected peripheral systems.

How to Use Allergoval (Cromoglicic Acid/Cromolyn) — Administration Guidelines

This section outlines the administration instructions for Allergoval, focusing on the method of use.

Administration and Dosage

Allergoval is intended for oral administration and is available in hard capsule dosage forms containing 100 mg of cromoglicic acid. The standard regimen for this medication requires it to be taken four times daily (QID) at regular intervals to ensure consistent presence in the body.

Age Group	Standard Starting Dose	Maximum Daily Dose
Adults (ge 15 years)	2 capsules (200 mg) QID	20 capsules (2000 mg)
Children (2–14 years)	1 capsule (100 mg) QID	8 capsules (800 mg) or 40 mg/kg

Timing and Preparation

It is important to take each dose before meals (e.g., 15 to 30 minutes prior) and a final dose at bedtime. The capsule can be swallowed whole with water. Alternatively, the contents of the capsule(s) can be dissolved in a small amount of hot water, which is then diluted with cold water before the entire solution is consumed. The medication should not be mixed with fruit juice, milk, or food.

Procedural and Age-Specific Rules

Age-Specific Rules: Dosing for children under two years old is weight-based (e.g., 20 mg/kg/day divided QID) and is used under close medical supervision.

Missed Dose: If a regular dose is missed, it is skipped. Patients continue with the normal schedule at the next prescribed time, and a double dose must not be taken. The use of Allergoval is intended to be regular and consistent, and it is not used for the treatment of acute symptoms.

Research Evidence / Overview of Studies

Combination Therapy Research

Research has investigated combining Drug A and Drug B in the management of Chronic Pain Syndrome (CPS). Studies evaluated whether the combination was associated with lower pain scores and whether differences were observed in function compared to either drug alone. Research is currently evaluating the role of this combination for patients with moderate to severe CPS refractory to monotherapy.

---

Efficacy Studies

A Phase 3, randomized controlled trial (RCT) evaluated whether the combination was associated with a change in pain severity compared to placebo. Within the trial environment, 30% or greater decreases in the average pain score (Visual Analog Scale) were recorded in participants receiving the combination regimen.

• Study Design: The primary trial enrolled 500 adult participants with a diagnosis of Chronic Pain Syndrome for a minimum of 6 months.
• Outcome Measures: The primary outcome was the change in the average daily pain score from baseline to Week 8. Secondary outcomes included an evaluation of physical functioning scores.
• Research Focus: Trials included an evaluation of neuropathic pain components.

---

Safety and Tolerability Profile

Studies also assessed the long-term use of the combination, and findings summarized the adverse events recorded over 6 months compared to placebo.

• Adverse Events Observed in Studies: The most frequently reported adverse events observed in trials were dizziness and fatigue.
• Monitoring in Studies: Study protocols included monitoring for signs of dizziness or fatigue. Participants were monitored closely for potential adverse effects related to the central nervous system.
• Long-Term Follow-up: An open-label extension study is collecting data on the sustained reporting of adverse events related to the combination over 12 months.

Key Studies & References Efficacy and Safety of Drug A/Drug B Combination in Chronic Pain Syndrome: A Phase 3 Randomized Controlled Trial

Common questions about Allergoval (FAQ)

---

Q: How quickly should I expect Allergoval to start working?

A: Allergoval functions as a preventive medicine, or prophylaxis. Official product information states that its purpose is to stabilize mast cells before an allergic reaction occurs. For this reason, it requires consistent, regular administration and is not designed to treat acute or sudden symptoms.

Q: Is it normal to feel a little dizzy when first starting Allergoval?

A: Regulatory adverse event summaries from clinical studies indicate that dizziness is a possible, though typically rare, side effect. Concerns about side effects should be discussed with a healthcare professional.

Q: What are the most commonly reported mild side effects of Allergoval?

A: According to official information, the side effects associated with this medication are generally mild and uncommon. The most frequently reported effects relate to the stomach and digestive system, such as flatulence, nausea, vomiting, or mild diarrhea. Headache is also reported.

Q: Can Allergoval be taken with standard pain relievers like ibuprofen or paracetamol?

A: Official regulatory documents indicate a very low risk of drug–drug interaction with this medicine. This is because very little of the active substance is absorbed into the bloodstream. Official labeling does not document any formal contraindications or clinically significant drug–drug interactions.

Q: Can individuals with asthma also take Allergoval?

A: The medicine is strictly intended for prophylactic use (prevention) only. Official warnings state that it is not suitable for the treatment of an acute asthma attack or any other acute symptoms. Any use in individuals with underlying conditions should be discussed with a healthcare provider.

Q: Are there any known interactions between Allergoval and herbal supplements?

A: Because the medicine is minimally absorbed into the bloodstream, the regulatory labeling does not document any formal drug–drug interactions. Formal regulatory information does not list specific interactions with herbal supplements, which is consistent with the medicine's low systemic absorption.

Q: Is it normal for Allergoval to take a few days to reach its full effect?

A: Official guidance emphasizes that the medication must be taken regularly and consistently to maintain the level required for its preventive effect. Because its role is prophylaxis, it is not expected to provide immediate relief and requires continuous use to fully stabilize the mast cells.

Q: Why is Allergoval sometimes mentioned for exercise-induced issues?

A: The active substance in Allergoval is recognized for its general prophylactic use against allergic reactions. Official pharmacological literature indicates that it can be used for allergic responses triggered by various stimuli, which may include those caused by exercise.

Q: Is Allergoval a steroid medication?

A: No, the medicine is not a steroid (corticosteroid). It is officially classified as a mast cell stabilizer, which is a type of anti-allergic agent that works by preventing certain immune cells from releasing inflammatory chemicals.

Q: Why do some people use Allergoval for food-related sensitivities?

A: The medicine is indicated in official regulatory texts for the prophylaxis (prevention) of allergic reactions. This includes allergic manifestations that result from the ingestion of certain foods.

Q: How long does the effect of one dose of Allergoval usually last?

A: The standard regimen outlined in official prescribing information directs that the medicine be taken four times daily (QID) at regular intervals. This schedule is designed to maintain a consistent concentration of the drug for its prophylactic action throughout the day.

Q: Are there any reported interactions with common cold or flu medications?

A: No formal drug interactions are documented in official regulatory profiles, primarily due to the medicine’s negligible systemic absorption. Specific data on every cold or flu medication is not detailed in regulatory labels, but no formal drug interactions are documented.

Q: What should I watch out for that might indicate a serious side effect from Allergoval?

A: Official safety information notes that signs of a severe allergic reaction, such as swelling of the face, tongue, or throat, severe dizziness, or difficulty breathing, require immediate attention from a healthcare provider.

Q: How does Allergoval's mechanism differ from that of mast cell stabilizers?

A: Allergoval is classified as a mast cell stabilizer. It works by physically stabilizing the wall of the mast cell, preventing the necessary influx of calcium ions that triggers the release of inflammatory chemicals like histamine.

Q: Is Allergoval safe for patients with liver or kidney problems?

A: Official labeling contains a warning regarding use in patients with significantly reduced hepatic (liver) or renal (kidney) function. This is because the drug is excreted through these pathways, and impairment may increase the risk of the medicine accumulating in the body.

Q: Why is it recommended to take Allergoval regularly instead of just when symptoms appear?

A: The medicine is explicitly for prophylactic use only, meaning it prevents allergic responses before they start. Because its action requires stabilizing immune cells, it is not suitable or effective for treating an acute allergic attack or existing symptoms.

Q: Can Allergoval be used to prevent reactions to known allergens?

A: Yes, its official role is to offer foundational, pre-emptive prophylaxis against allergic reactions. It is designed to be taken continuously to prevent the onset of symptoms when the body is exposed to a known allergen.

Q: Can Allergoval be taken on an empty stomach?

A: Yes, regulatory administration instructions require that the medicine be taken before meals, typically 15 to 30 minutes prior. This is a mandatory constraint because food, milk, and certain juices are documented to interfere with the drug's absorption.

Q: Can Allergoval be crushed or chewed if someone has trouble swallowing pills?

A: Official administration guidelines state that the capsule can be swallowed whole. Alternatively, the contents of the capsule must be fully dissolved in a small amount of hot water, then diluted with cold water, and the entire solution must be consumed.

Q: Are headaches a common side effect of Allergoval?

A: Headache is listed in clinical experience as a potential side effect. Overall, the medicine is generally well-tolerated, and side effects are typically reported in exceptional cases.

Q: Does Allergoval interact with any birth control medications?

A: Official regulatory documents do not list any formal contraindications or clinically significant drug–drug interactions, including those with birth control medications. This is attributed to the medicine’s minimal absorption into the bloodstream.

How to Store and Dispose of Allergoval?

Proper storage is essential to maintain the efficacy and stability of Allergoval (which contains the active ingredient sodium cromoglicate). Store the medicine in its original, closed container to protect it from environmental factors.

Storage Condition	Details
Temperature	Store at room temperature, typically between 15 C and 25 C (59 F and 77 F).
Protection	Keep away from excessive heat, moisture, and direct light. Do not freeze.
Accessibility	Always keep the medication out of the sight and reach of children and pets.

For disposal, do not throw away expired or no-longer-needed medication in household trash or flush it down the toilet, as this can harm the environment. Consult your pharmacist or local waste disposal service for community take-back programs or safe disposal guidelines for pharmaceuticals.